Detalhe da pesquisa
1.
Having More Tender Than Swollen Joints Is Associated With Worse Patient-Reported Outcomes in Patients With Early RA.
J Clin Rheumatol
; 2024 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38689390
2.
Efficacy of subcutaneous vs intravenous infliximab in rheumatoid arthritis: a post-hoc analysis of a randomized phase III trial.
Rheumatology (Oxford)
; 62(8): 2838-2844, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36534825
3.
Medical cannabis use by rheumatology patients in routine clinical care: results from The Ontario Best Practices Research Initiative.
Clin Exp Rheumatol
; 41(1): 118-125, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-35616591
4.
"From Where I Stand": using multiple anchors yields different benchmarks for meaningful improvement and worsening in the rheumatoid arthritis flare questionnaire (RA-FQ).
Qual Life Res
; 32(5): 1307-1318, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36074252
5.
The Proportion of Patients With Rheumatoid Arthritis Achieving ACR20/50/70; Consistent Patterns of a 60/40/20 as Demonstrated by a Systematic Review and Meta-analysis.
J Clin Rheumatol
; 29(4): 183-189, 2023 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36870081
6.
Does the Type of Failure and the Choice of the Second Biologic Influence Response and Persistence on Medication in Rheumatoid Arthritis?
J Clin Rheumatol
; 29(7): 332-340, 2023 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37644656
7.
Safety and efficacy of filgotinib for Japanese patients with RA and inadequate response to MTX: FINCH 1 52-week results and FINCH 4 48-week results.
Mod Rheumatol
; 33(4): 668-679, 2023 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35920102
8.
Efficacy and safety of switching from reference adalimumab to CT-P17 (100 mg/ml): 52-week randomized, double-blind study in rheumatoid arthritis.
Rheumatology (Oxford)
; 61(4): 1385-1395, 2022 04 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34142111
9.
Differential influence of Clinical Disease Activity Index components based on disease state in rheumatoid arthritis patients: real-world results from the Ontario Best Practices Research Initiative.
Clin Exp Rheumatol
; 40(11): 2147-2152, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-35383561
10.
Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1).
Mod Rheumatol
; 32(2): 263-272, 2022 Feb 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34910188
11.
Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial.
Ann Rheum Dis
; 80(7): 848-858, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33504485
12.
Randomised, phase I pharmacokinetic study of adalimumab biosimilar CT-P17 (40 mg/0.4 mL) by autoinjector and prefilled syringe in healthy subjects.
Br J Clin Pharmacol
; 87(11): 4323-4333, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33822406
13.
Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis.
N Engl J Med
; 376(7): 652-662, 2017 02 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28199814
14.
Disease activity measures at baseline predict structural damage progression: data from the randomized, controlled AMPLE and AVERT trials.
Rheumatology (Oxford)
; 59(8): 2090-2098, 2020 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31819995
15.
Tofacitinib in combination with methotrexate in patients with rheumatoid arthritis: patient-reported outcomes from the 24-month Phase 3 ORAL Scan study.
Clin Exp Rheumatol
; 38(5): 848-857, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31858963
16.
Clinical outcomes in patients switched from adalimumab to baricitinib due to non-response and/or study design: phase III data in patients with rheumatoid arthritis.
Ann Rheum Dis
; 78(7): 890-898, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31040122
17.
Elucidating the endogenous synovial fluid proteome and peptidome of inflammatory arthritis using label-free mass spectrometry.
Clin Proteomics
; 16: 23, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31160890
18.
Efficacy and safety of tregalizumab in patients with rheumatoid arthritis and an inadequate response to methotrexate: results of a phase IIb, randomised, placebo-controlled trial.
Ann Rheum Dis
; 77(4): 495-499, 2018 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29343509
19.
Triple Therapy Versus Biologic Therapy for Active Rheumatoid Arthritis: A Cost-Effectiveness Analysis.
Ann Intern Med
; 167(1): 8-16, 2017 07 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28554192
20.
Patient-reported outcomes from a phase 3 study of baricitinib versus placebo or adalimumab in rheumatoid arthritis: secondary analyses from the RA-BEAM study.
Ann Rheum Dis
; 76(11): 1853-1861, 2017 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-28798049